CYTOSORBENTS CORPORATION - COMMON STOCK

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

04 мар 2025 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

26 фев 2025 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants

25 фев 2025 06:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: CYTOSORBENTS CORPORATION - COMMON STOCK

14 фев 2025 14:29:08 Источник NetDania Notify

CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering

13 янв 2025 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai

06 янв 2025 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

03 янв 2025 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Rights Offering Begins

23 дек 2024 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Announces Rights Offering

09 дек 2024 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference

26 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India

11 ноя 2024 06:30:00 Источник Nasdaq GlobeNewswire

CytoSorbents Reports Third Quarter 2024 Financial and Operational Results

07 ноя 2024 15:05:02 Источник Nasdaq GlobeNewswire

CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification

04 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review

22 окт 2024 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents to Report Third Quarter 2024 Operating and Financial Results

17 окт 2024 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update

01 окт 2024 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference

27 авг 2024 06:00:00 Источник Nasdaq GlobeNewswire

CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16 авг 2024 15:05:00 Источник Nasdaq GlobeNewswire

CytoSorbents Reports Second Quarter 2024 Financial and Operational Results

13 авг 2024 15:19:55 Источник Nasdaq GlobeNewswire

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

13 авг 2024 15:18:28 Источник Nasdaq GlobeNewswire